The present invention relates to the use of compositions comprising a derivative of Cannabis saliva, preferably cannabidiol (CBD), and at least one bacterial strain in methods for the therapeutic treatment of functional diseases of the gastrointestinal tract and of associated symptoms, of diseases associated with chronic pain, of joint problems and/or of diseases or symptoms associated with an impaired intestinal permeability.
展开▼
